15-67204104-T-TG
Position:
Variant summary
Our verdict is Likely pathogenic. Variant got 9 ACMG points: 10P and 1B. PVS1PP5_ModerateBS2_Supporting
The NM_024666.5(AAGAB):c.759_760insC(p.Thr254HisfsTer10) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000685 in 1,460,194 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000068 ( 0 hom. )
Consequence
AAGAB
NM_024666.5 frameshift
NM_024666.5 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.272
Genes affected
AAGAB (HGNC:25662): (alpha and gamma adaptin binding protein) The protein encoded by this gene interacts with the gamma-adaptin and alpha-adaptin subunits of complexes involved in clathrin-coated vesicle trafficking. Mutations in this gene are associated with type I punctate palmoplantar keratoderma. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Dec 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 9 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PP5
Variant 15-67204104-T-TG is Pathogenic according to our data. Variant chr15-67204104-T-TG is described in ClinVar as [Pathogenic]. Clinvar id is 2872740.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High AC in GnomAdExome4 at 10 AD gene. Variant has AC lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
AAGAB | NM_024666.5 | c.759_760insC | p.Thr254HisfsTer10 | frameshift_variant | 8/10 | ENST00000261880.10 | |
AAGAB | NM_001271885.2 | c.432_433insC | p.Thr145HisfsTer10 | frameshift_variant | 8/10 | ||
AAGAB | NM_001271886.2 | c.432_433insC | p.Thr145HisfsTer10 | frameshift_variant | 8/10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
AAGAB | ENST00000261880.10 | c.759_760insC | p.Thr254HisfsTer10 | frameshift_variant | 8/10 | 1 | NM_024666.5 | P1 | |
AAGAB | ENST00000542650.5 | c.432_433insC | p.Thr145HisfsTer10 | frameshift_variant | 8/10 | 2 | |||
AAGAB | ENST00000561452.5 | c.432_433insC | p.Thr145HisfsTer10 | frameshift_variant | 8/10 | 5 | |||
AAGAB | ENST00000538028.1 | n.440_441insC | non_coding_transcript_exon_variant | 5/7 | 2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD3 exomes AF: 0.0000121 AC: 3AN: 248822Hom.: 0 AF XY: 0.00000740 AC XY: 1AN XY: 135056
GnomAD3 exomes
AF:
AC:
3
AN:
248822
Hom.:
AF XY:
AC XY:
1
AN XY:
135056
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000685 AC: 10AN: 1460194Hom.: 0 Cov.: 29 AF XY: 0.00000551 AC XY: 4AN XY: 726482
GnomAD4 exome
AF:
AC:
10
AN:
1460194
Hom.:
Cov.:
29
AF XY:
AC XY:
4
AN XY:
726482
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 10, 2023 | This sequence change creates a premature translational stop signal (p.Thr254Hisfs*10) in the AAGAB gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in AAGAB are known to be pathogenic (PMID: 23000146, 23064416, 23563198, 23633024, 24390136). This variant is present in population databases (rs765401006, gnomAD 0.003%). This variant has not been reported in the literature in individuals affected with AAGAB-related conditions. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at